Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06550453
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-02
Brief Title:
Safety and Efficacy of Pembrolizumab in Combination With Bevacizumab CapeOX in the Neoadjuvant Treatment of RAS-mutated BRAF Wild-type Microsatellite-stabilized Locally Advanced Colorectal Cancer
Sponsor:
Organization:
None